🔗 Share this article

Chancellor Reeves has announced she is preparing "targeted steps to deal with household expense issues" in the upcoming financial statement.

In comments to media outlets, she noted that reducing price rises is a joint responsibility of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Possible Energy Cost Interventions

Reports indicate the government could take action to lower utility costs, for instance by slashing the current 5% rate of VAT charged on energy supplies.

An additional approach is to reduce some of the government charges currently added to bills.

Fiscal Limitations and Expert Predictions

The government will receive the latest report from the official forecaster, the OBR, on the start of the week, which will show how much space there is for these measures.

The consensus from most experts is that the Chancellor will have to introduce tax increases or expenditure reductions in order to adhere to her voluntary fiscal targets.

Earlier on the same day, estimates showed there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of expectations.

"It is a shared responsibility between the Bank of England and the government to further reduce some of the sources of inflation," the Chancellor stated to the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Pledges and Global Issues

While much of the focus has been on likely tax rises, the chancellor said the most recent information from the OBR had not altered her pledge to campaign commitments not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with growing international and commercial concerns for the Budget tax moves, probably to be directed on those "with the broadest shoulders."

International Economic Disputes

Commenting on apprehensions about the UK's commercial links with the Asian nation she said: "Our national security invariably take priority."

Recent statement by China to tighten export controls on rare earths and other materials that are crucial for high-technology production led US President the US President to propose an further 100% tariff on goods from the Asian country, increasing the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief called the Chinese move "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to join its conflict with China, Reeves said she was "extremely troubled" by China's actions and called on the Chinese government "to avoid restrictions and limit trade."

She said the decision was "harmful for the international commerce and creates further challenges."

"I believe there are areas where we must challenge China, but there are also important chances to sell into China's economy, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium correct."

The chancellor also confirmed she was cooperating with international partners "regarding our own essential resources approach, so that we are less reliant."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the cost the National Health Service pays for drugs could go up as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the world's largest drug companies have said in recent statements that they are either delaying or canceling investments in the United Kingdom, with some blaming the insufficient payments they are obtaining.

Last month, the government science advisor said the price the NHS pays for drugs would need to increase to prevent companies and drug research funding leaving the UK.

The Chancellor stated to media: "We have seen because of the payment system, that clinical trials, new drugs have not been offered in the UK in the extent that they are in other continental states."

"The objective is to guarantee that patients receiving care from the National Health Service are able to receive the finest essential medicines in the world. And so we are looking at these issues, and... aiming to secure additional capital into Britain."